Asterias Biotherapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 39
Rang # Quantité totale PI 35 876
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 40 923

Brevets

Marques

25 0
8 0
6 0
0
 
Dernier brevet 2024 - Compositions and methods for tre...
Premier brevet 1998 - Methods and materials for the gr...

Derniers inventions, produits et services

2024 Invention Oligodendrocyte progenitor cell compositions. Compositions comprising a population of oligodendr...
Invention Suspension culture of human embryonic stem cells. This disclosure provides an improved system fo...
2023 Invention Differentiation and enrichment of islet-like cells from human pluripotent stem cells. Methods fo...
Invention Compositions and methods for treating spinal cord injuries. Provided herein are methods, composi...
Invention Compositions and methods for treating spinal cord injuries. Provided herein are methods, composit...
2022 Invention Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells. Methods for...
2021 Invention Pluripotent stem cell-derived oliogodendrocyte progenitor cells for the treatment of spinal cord ...
2020 Invention Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells. Methods for ...
2019 Invention Methods for differentiating pluripotent stem cells in dynamic suspension culture. Methods for di...
Invention Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord i...
Invention Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells. Synthetic s...
2018 Invention Suspension culture of human embryonic stem cells. This disclosure provides an improved system for...
Invention Chondrocyte precursors derived from human embryonic stem cells. This invention provides a system...
2017 Invention Neural cell populations from primate pluripotent stem cells. This invention provides a system for...
Invention Oligodendrocyte progenitor cell compositions. Compositions comprising a population of oligodendro...
Invention Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells. Synthetic su...
Invention Differentiation of primate pluripotent stem cells to hematopoietic lineage cells. The invention p...
2016 Invention Stem cell-derived oligodendrocyte progenitor cells for the treatment of white matter stroke. In ...
Invention Stem cell-derived oligodendrocyte progenitor cells for the treatment of white matter stroke. In v...
Invention Synthetic surfaces for culturing stem cell derived cardiomyocytes. Synthetic surfaces suitable fo...
Invention Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells. The invention p...
2015 Invention Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes. The invention pr...
Invention Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells. The present ap...
2014 Invention Islet cells from human embryonic stem cells. This disclosure provides a system for producing pan...
Invention Neural progenitor cell populations. This invention provides populations of neural progenitor cel...
2013 Invention Protocols for making hepatocytes from embryonic stem cells. This disclosure provides a newly deve...
Invention Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic ...
2012 Invention Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes. The invention pro...
2010 Invention Primate pluripotent stem cell expansion without feeder cells and in the presence of fgf and matri...